Use of polymyxins in Chinese hospitals
Lancet Infect Dis
.
2020 Oct;20(10):1125-1126.
doi: 10.1016/S1473-3099(20)30696-4.
Authors
Rong Zhang
1
,
Yingbo Shen
2
,
Timothy R Walsh
3
,
Yang Wang
4
,
Fupin Hu
5
Affiliations
1
The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
2
CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology, Chinese Academy of Sciences, Beijing, China.
3
Department of Zoology, University of Oxford, Oxford, UK.
4
College of Veterinary Medicine, China Agricultural University, Beijing, China.
5
Institute of Antibiotics, Huashan Hospital, Fudan University, Shanghai, 200040 China. Electronic address: hufupin@fudan.edu.cn.
PMID:
32979324
DOI:
10.1016/S1473-3099(20)30696-4
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Anti-Bacterial Agents
China
Colistin
One Health*
Polymyxins*
Substances
Anti-Bacterial Agents
Polymyxins
Colistin
Grants and funding
MR/S013768/1/MRC_/Medical Research Council/United Kingdom
MR/S013768/2/MRC_/Medical Research Council/United Kingdom